Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01481
|
|||||
| Drug Name |
E-guggulsterone
|
|||||
| Synonyms |
Guggulsterone E; (E)-Guggulsterone; E-Guggulsterone; Guggulsterones E; trans-Guggulsterone; 39025-24-6; Pregna-4,17-diene-3,16-dione; UNII-9B259YE66O; (17E)-Pregna-4,17(20)-diene-3,16-dione; Z-Guggulsterone; CHEMBL402063; 95975-55-6; 9B259YE66O; (8R,9S,10R,13S,14S,17E)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione; E-Guggulsteron; Pregna-4,17(20)-diene-3,16-dione; Guggulsterone, (E)-; Guglip; Z/E-Guggulsterone; Pregna-4,17(20)-diene-3,16-dione, (17E)-; Guggulsterone E; Guggulsterones Z; Cis-Guggulsterone; Trans-Guggulsterone; (17E)-pregna-4,17-diene-3,16-dione; (17Z)-Pregna-4,17(20)-diene-3,16-dione; (17Z)-pregna-4,17-diene-3,16-dione; (8R,9S,10R,13S,14S,17Z)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione; (Z)-Guggulsterone; 4,17(20)-cis-Pregnadiene-3,16-dione; E-GUGGULSTERONE
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Osteoarthritis [ICD11: FA0Z] | Preclinical | [1] | |||
| Therapeutic Class |
Antiinflammatory Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H28O2
|
|||||
| Canonical SMILES |
CC=C1C(=O)CC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
|
|||||
| InChI |
InChI=1S/C21H28O2/c1-4-16-19(23)12-18-15-6-5-13-11-14(22)7-9-20(13,2)17(15)8-10-21(16,18)3/h4,11,15,17-18H,5-10,12H2,1-3H3/b16-4-/t15-,17+,18+,20+,21-/m1/s1
|
|||||
| InChIKey |
WDXRGPWQVHZTQJ-AUKWTSKRSA-N
|
|||||
| CAS Number |
CAS 95975-55-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 312.4 | Topological Polar Surface Area | 34.1 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
3.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
11968418
, 12014199
, 14776672
, 16785310
, 17388984
, 43032812
, 47290858
, 48425176
, 53786929
, 57368784
, 75135369
, 103557435
, 104097121
, 114560011
, 121277970
, 124891536
, 126662501
, 134338597
, 134345283
, 135102533
, 135232087
, 135652690
, 137267509
, 137267510
, 144207512
, 152035987
, 162175698
, 162247924
, 177749507
, 179323901
, 180100214
, 198955980
, 198979541
, 223686210
, 227839216
, 241068353
, 249617470
, 252156260
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Guggulsterone, a farnesoid X receptor antagonist lowers plasma trimethylamine- N-oxide levels: An evidence from in vitro and in vivo studies. Hum Exp Toxicol. 2018 Dec 9:960327118817862. | |||||
| 2 | Effects of plant sterols on human multidrug transporters ABCB1 and ABCC1. Biochem Biophys Res Commun. 2008 May 2;369(2):363-8. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.